Skip to main content
. Author manuscript; available in PMC: 2021 Aug 27.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Sep 5;28(11):1816–1824. doi: 10.1158/1055-9965.EPI-19-0239

Table 5.

Hierarchical ORs for CIN3+ for hrHPV genotypes and for different viral load groups [high, intermediate (Inter), and low], ordered by the genotype hierarchy and weighted to the statewide population of women

HPV type Viral load (N, %) OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Any hrHPVa High (18,541, 0.6) 77.31 (46.48–128.61) 9.4E-63 4.94 (3.35–7.28) 8.1E-16 2.53 (2.00–3.19) 6E-15
Inter (13,374, 0.4) 30.57 (17.87–52.30) 1.0E-35 1.95 (1.28–2.98) 2.0E-03 Ref.
Low (18,558, 0.6) 15.66 (8.42–29.11) 3.6E-18 Ref.
Negative (277,954, 84.6) Ref.
P value (trend) 2.6E-123 3.0E-20
16 High (6,171, 1.9) 55.28 (44.27–69.03) 5.3E-271 5.48 (2.57–11.67) 1.1E-05 3.18 (2.16–4.69) 5.1E-09
Inter (2,431, 0.7) 17.36 (11.56–26.08) 6.1E-43 1.72 (0.75–3.94) 0.20 Ref.
Low (2,844, 0.9) 10.09 (4.70–21.67) 3.1E-09 Ref.
Negative (316,981, 96.5) Ref.
P value (trend) 2.8E-286 4.7E-08
33 High (564, 0.2) 20.42 (10.45–39.92) 1.2E-18 4.04 (1.07–15.32) 0.04 0.62 (0.21–1.83) 0.39
Inter (287, 0.1) 32.97 (13.56–80.19) 1.3E-14 6.53 (1.53–27.84) 0.01 Ref.
Low (509, 0.2) 5.05 (1.55–16.46) 7.2E-03 Ref.
Negative (315,622, 96.1) Ref.
P value (trend) 1.6E-31 0.04
31 High (781, 0.2) 11.27 (4.76–26.65) 3.5E-08 1.01 (0.39–2.61) 0.98 0.40 (0.16–0.99) 0.05
Inter (1,807, 0.6) 28.28 (18.23–43.88) 3.6E-50 2.53 (1.40–4.59) 2.2E-03 Ref.
Low (2,551, 0.8) 11.16 (6.65–18.72) 6.7E-20 Ref.
Negative (310,483, 94.5) Ref.
P value (trend) 1.2E-65 0.14
18 High (1,553, 0.5) 18.07 (11.03–29.61) 1.5E-30 2.05 (0.70–6.02) 0.19 2.69 (0.90–8.09) 0.08
Inter (675, 0.2) 6.71 (2.36–19.08) 3.6E-04 0.76 (0.18–3.14) 0.70 Ref.
Low (855, 0.3) 8.83 (3.17–24.57) 3.0E-05 Ref.
Negative (307,399, 93.6) Ref.
P value (trend) 2.8E-34 0.14
35 High (330, 0.1) 19.30 (7.36–50.60) 1.8E-09 2.97 (0.70–12.70) 0.14 1.27 (0.41–3.97) 0.68
Inter (848, 0.3) 15.16 (7.43–30.91) 7.7E-14 2.34 (0.64–8.52) 0.20 Ref.
Low (1,032, 0.3) 6.49 (2.06–20.43) 1.4E-03 Ref.
Negative (305,189, 92.9) Ref.
P value (trend) 2.8E-23 0.09
58 High (1,483, 0.5) 18.46 (10.69–31.89) 1.5E-25 10.33 (1.36–78.49) 0.02 7.87 (1.03–60.04) 0.05
Inter (595, 0.2) 2.35 (0.32–17.34) 0.40 1.31 (0.08–21.63) 0.85 Ref.
Low (781, 0.2) 1.79 (0.24–13.15) 0.57 Ref.
Negative (302,329, 92.1) Ref.
P value (trend) 1.8E-23 0.01
45 High (919, 0.3) 9.56 (3.94–23.17) 5.8E-07 0.85 (0.22–3.32) 0.82 0.87 (0.22–3.44) 0.84
Inter (749, 0.2) 11.03 (3.51–34.68) 4.0E-05 0.98 (0.21–4.62) 0.98 Ref.
Low (928, 0.3) 11.24 (3.62–34.90) 2.8E-05 Ref.
Negative (299,734, 91.3) Ref.
P value (trend) 1.4E-13 0.82
52 High (1,391, 0.4) 27.06 (14.70–49.82) 3.6E-26 9.93 (2.86–34.39) 3.0E-04 3.10 (1.12–8.57) 0.03
Inter (1,458, 0.4) 8.73 (3.31–23.01) 1.2E-05 3.20 (0.75–13.70) 0.12 Ref.
Low (1,888, 0.6) 2.73 (0.82–9.08) 0.10 Ref.
Negative (294,996, 89.8) Ref.
P value (trend) 3.7E-26 9.9E-05
59 High (2,164, 0.7) 18.65 (4.91–70.94) 1.8E-05 3.62 (0.50–26.11) 0.20 2.34 (0.39–14.08) 0.35
Inter (1,129, 0.3) 7.98 (2.10–30.27) 2.3E-03 1.55 (0.21–11.20) 0.66 Ref.
Low (1,375, 0.4) 5.15 (1.08–24.64) 0.04 Ref.
Negative (290,328, 88.4) Ref.
P value (trend) 1.7E-06 0.20
51 High (876, 0.3) 8.03 (2.36–27.36) 8.7E-04 0.50 (0.07–3.56) 0.48 0.70 (0.15–3.38) 0.66
Inter (1,466, 0.4) 11.42 (3.56–36.65) 4.3E-05 0.70 (0.10–4.86) 0.72 Ref.
Low (2,292, 0.7) 16.21 (3.08–85.18) 1.0E-03 Ref.
Negative (285,694, 87.0) Ref.
P value (trend) 3.5E-10 0.55
39 High (978, 0.3) 13.03 (4.72–36.00) 7.4E-07 5.65 (1.07–29.71) 0.04 1.48 (0.25–8.68) 0.67
Inter (1,008, 0.3) 8.83 (1.78–43.85) 7.7E-03 3.83 (0.48–30.33) 0.20 Ref.
Low (2,122, 0.6) 2.31 (0.53–10.09) 0.27 Ref.
Negative (281,587, 85.7) Ref.
P value (trend) 9.6E-08 0.03
56 High (750, 0.2) 7.18 (1.62–31.72) 9.3E-03
Inter (446, 0.1)
Low (975, 0.3)
Negative (279,416, 85.1) Ref.
P value (trend) 0.10
68 High (591, 0.2) 4.21 (0.55–32.39) 1.7E-01
Inter (469, 0.1)
Low (402, 0.1)
Negative (277,953, 84.6) Ref.
P value (trend) 0.39

NOTE: Multiple HPV infections with types ranked higher in the hierarchy are excluded. Separate analyses are shown with low and intermediate viral loads as the reference category.

a

Highest ranked hrHPV type per woman.